INITIATION AND REGULATION OF BLOOD COAGULATION

凝血的启动和调节

基本信息

项目摘要

Tissue factor (TF)-dependent blood coagulation plays a primary role in hemostasis after tissue injury and also in pathogenesis. Binding of factor VII to TF is the initial step in TF-dependent blood coagulation. A key reaction must then follow: activation of the bound factor VII to give rise to catalytically active VIIa/TF complexes. Little is known about how the activation of factor VII and the subsequent VIIa/TF-catalytic activity are regulated in vivo and to what extent anti-coagulantly active cell surface heparin sulfate proteoglycans play a role in the regulation of these critical steps in TF-induced coagulation. Further, which specific amino acid side chains in VIIa and TF are involved in the recognition of tissue factor pathway inhibitor (TFPI) and the cell biology of VIIa/TF remain unknown. The primary focus of the present proposal is to obtain important information on these unanswered questions. The specific goals are: (1) Test a hypothesis, both in vitro and in vivo, that cell surface heparin sulfate proteoglycans limit activation of factor VII bound to TF expressed on cell surfaces and thereby regulated TF-induced coagulation (2) Test a hypothesis that recognition structures for substrate factor X presents in VIIa/TF complex contribute to the enhancing effect of Xa during the quaternary complex formation of VIIa/TF/TFPI/Xa (3) Test a hypothesis that cell surface TF redistributes upon complex formation with VIIa, Xa and TFPI and define the role of TFPI in this process (4) Test a hypothesis that the binding of TFPI/Xa to cell surface VIIa/TF affects internalization of cell surface VIIa/TF complexes and elucidate the intracellular trafficking of internalized VIIa and TF. In the proposed studies, various well established techniques, such as radioligand binding, coagulation assays, electron microscopy, and a rabbit intravascular coagulation model system will be used. Information obtained from these studies will aid in understanding important clinical issues, such as why infused factor VIIa is effective in controlling the bleeding in hemophiliacs. The above studies will further our understanding of the structural mechanism of macromolecular assembly of VIIa/TF/TFPI/Xa. Such an understanding may lead to the design and application of therapeutic measures aimed at the treatment of hemorrhagic disease and thrombotic complications.
组织因子(TF)依赖性凝血在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vijaya Mohan Rao Lella其他文献

Vijaya Mohan Rao Lella的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vijaya Mohan Rao Lella', 18)}}的其他基金

Tissue Factor's Role in the Pathogenesis of Hypercoagulability in COVID-19
组织因子在 COVID-19 高凝状态发病机制中的作用
  • 批准号:
    10448667
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
Tissue Factor's Role in the Pathogenesis of Hypercoagulability in COVID-19
组织因子在 COVID-19 高凝状态发病机制中的作用
  • 批准号:
    10580840
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
The Role of Gab2 Signaling in Thromboinflammation
Gab2 信号传导在血栓炎症中的作用
  • 批准号:
    10448670
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
Membrane Phospholipids: The Key Regulator of Tissue Factor Encryption/Decryption
膜磷脂:组织因子加密/解密的关键调节剂
  • 批准号:
    9054915
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Membrane Phospholipids: The Key Regulators of Tissue Factor Encryption/Decryption
膜磷脂:组织因子加密/解密的关键调节剂
  • 批准号:
    10153855
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Membrane Phospholipids: The Key Regulators of Tissue Factor Encryption/Decryption
膜磷脂:组织因子加密/解密的关键调节剂
  • 批准号:
    10401806
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Membrane Phospholipids: The Key Regulator of Tissue Factor Encryption/Decryption
膜磷脂:组织因子加密/解密的关键调节剂
  • 批准号:
    8885418
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Membrane Phospholipids: The Key Regulators of Tissue Factor Encryption/Decryption
膜磷脂:组织因子加密/解密的关键调节剂
  • 批准号:
    10615732
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Factor VIIa interaction with Endothelial Cell Protein C Receptor
因子 VIIa 与内皮细胞蛋白 C 受体的相互作用
  • 批准号:
    9328143
  • 财政年份:
    2012
  • 资助金额:
    $ 17.83万
  • 项目类别:
Factor VIIa Interaction with Endothelial Cell Protein C Receptor
因子 VIIa 与内皮细胞蛋白 C 受体的相互作用
  • 批准号:
    8403678
  • 财政年份:
    2012
  • 资助金额:
    $ 17.83万
  • 项目类别:

相似海外基金

Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10722686
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
  • 批准号:
    10571353
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
Elucidation of changes in electrical properties during the blood coagulation process and its use for measurement of blood coagulation status during extracorporeal circulation
阐明血液凝固过程中电特性的变化及其在体外循环期间血液凝固状态测量中的应用
  • 批准号:
    23K08266
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Innovative Platform for Low Volume Blood Coagulation Analysis
SBIR II 期:低容量凝血分析的创新平台
  • 批准号:
    2134020
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Cooperative Agreement
Construction of a multilayered network to represent blood coagulation process
构建代表血液凝固过程的多层网络
  • 批准号:
    22K12252
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
  • 批准号:
    10616732
  • 财政年份:
    2022
  • 资助金额:
    $ 17.83万
  • 项目类别:
Development of thrombus prevention technology for ECMO devices based on the blood coagulation mechanism caused by viral infections
基于病毒感染凝血机制的ECMO装置血栓预防技术开发
  • 批准号:
    21K08817
  • 财政年份:
    2021
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10452687
  • 财政年份:
    2021
  • 资助金额:
    $ 17.83万
  • 项目类别:
SBIR Phase II: CoagCare-A POC Blood Coagulation Diagnostic Platform That Utilizes A Hand-held Meter and Mechanically Sensitive Test Strips for Broad Spectrum Hemostasis Monitoring
SBIR II 期:CoagCare - POC 凝血诊断平台,利用手持式仪表和机械敏感试纸条进行广谱止血监测
  • 批准号:
    2050272
  • 财政年份:
    2021
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Cooperative Agreement
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10283268
  • 财政年份:
    2021
  • 资助金额:
    $ 17.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了